0 107

Cited 0 times in

Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.

DC FieldValueLanguage
dc.contributor.author이옥희-
dc.date.accessioned2014-12-20T17:08:34Z-
dc.date.available2014-12-20T17:08:34Z-
dc.date.issued2011-
dc.identifier.issn0223-5234-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/94042-
dc.description.abstractEpoxide ring-opened xanthone derivatives were synthesized and tested for their topoisomerase inhibitory activity and cytotoxicity. Most of the compounds showed topo IIα specific inhibitory activity. To clarify the mechanism of action of these compounds, the most potent compound (compound 14) of the synthesized analogues was further studied by testing its ATPase inhibitory activity and through molecular docking experiments. The results showed that the topo IIα inhibitory activity of compound 14 was inversely proportional to ATP concentration. In the ATPase inhibitory test, ATP hydrolysis was reduced less efficiently by compound 14 (28.5±4.6%) than novobiocin (60.4±8.1%). Molecular docking study revealed compound 14 to have a stable binding pattern to the ATP-binding domain of human topo II.-
dc.description.statementOfResponsibilityopen-
dc.format.extent1964~1971-
dc.relation.isPartOfEuropean Journal of Medicinal Chemistry-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleSynthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.-
dc.typeArticle-
dc.contributor.collegeResearcher Institutes (부설 연구소)-
dc.contributor.departmentYonsei Integrative Research Institute for Cerebral & Cardiovascular Disease (뇌심혈관질환융합연구사업단)-
dc.contributor.googleauthorKyu-Yeon Jun-
dc.contributor.googleauthorEun-Young Lee-
dc.contributor.googleauthorMi-Ja Jung-
dc.contributor.googleauthorOk-Hee Lee-
dc.contributor.googleauthorEung-Seok Lee-
dc.contributor.googleauthorHea-Young Park Choo-
dc.contributor.googleauthorYounghwa Na-
dc.contributor.googleauthorYoungjoo Kwon-
dc.identifier.doi10.1016/j.ejmech.2011.01.011-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02970-
dc.relation.journalcodeJ00829-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0223523411000195-
dc.contributor.alternativeNameLee, Ok Hee-
dc.contributor.affiliatedAuthorLee, Ok Hee-
dc.identifier.localIdT201103203-
dc.rights.accessRightsnot free-
dc.citation.volume46-
dc.citation.number6-
dc.citation.startPage1964-
dc.citation.endPage1971-
dc.identifier.bibliographicCitationEuropean Journal of Medicinal Chemistry, Vol.46(6) : 1964-1971, 2011-
Appears in Collections:
1. Journal Papers (연구논문) > 5. Research Institutes (연구소) > Yonsei Integrative Research Institute for Cerebral & Cardiovascular Disease (뇌심혈관질환융합연구사업단)

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.